Pharmaceuticals are special products due to special characteristics in supply and demand. Their distribution is heavily regulated to ensure that drugs are accessible, affordable, and safely consumed. Competition can and should play a role in ensuring that the pharmaceuticals distribution market works well for consumers. The 2014 Global Forum on Competition addressed competition issues in the distribution of pharmaceuticals.
English, PDF, 1,050kb
This report by OECD and UNCTAD compiles G20 investment measures taken between 2 April 2009 and 15 October 2014.
Nationally and internationally competitive markets should be promoted in order to provide consumers with greater choice amongst financial services. The OECD Competition Committee discussed the Role of Competition in Financial Consumer Protection in February 2014.
The Capital Movements Code provides a balanced framework for capital account openness. It is the only multilateral legal instrument with comprehensive coverage of capital movements. This includes inflows and outflows, long-term and short-term operations.
English, PDF, 687kb
This report publishes the country lists of measures other than “exceptions to national treatment” notified for transparency purposes by adherents to the OECD Declaration on International Investment and Multinational Enterprises. Lists of exceptions under the National Treatment instrument are published in a separate document available at www.oecd.org/daf/inv/investment-policy/nti.htm.
This public consultation was held to gather interested stakeholders' comments on the draft chapters of the Policy Framework for Investment currently being updated. The consultation ran until 31 December 2014.